ALCHEMAB THERAPEUTICS LTD
Research and experimental development on biotechnology
ALCHEMAB THERAPEUTICS LTD
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
East Side Office 1.02 Kings Cross London N1C 4AX United Kingdom
Full company profile for ALCHEMAB THERAPEUTICS LTD (12156844), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 14 Aug 2019. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2021–2024)
Cash in Bank
£15.58M
Net Assets
-£9.34M
Total Liabilities
£31.77M
Turnover
£1.59M
Employees
60
Debt Ratio
142%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
See all 4 funding rounds
Sign up to view complete fundraising history
Investors (8)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 6 | Jun 2019 | Seed, Series A |
| Investor 5 | Jun 2020 | Seed |
| Investor 3 | Apr 2021 | Series A |
See all 8 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Jane Katharine Osbourn | Director | British | England | 11 Sept 2024 | Active |
| Kevin Lee | Director | English | England | 30 Jun 2021 | Active |
See all 12 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
Dementia Discovery Gp Lp
Ceased 2 Apr 2020
Sv7 (imf) Gp Llp
Ceased 13 Apr 2021
Group Structure
Group Structure
No group structure identified
Charges
Charges
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 10 Mar 2026 | Officers | Change Person Secretary Company With Change Date | |
| 10 Mar 2026 | Officers | Appointment of Mr Malcolm Gates as director on 2026-03-05 | |
| 12 Dec 2025 | Confirmation Statement | Confirmation statement made on 2025-11-28 with updates | |
| 20 Nov 2025 | Capital | Allotment of shares (GBP 7,774.5756) on 2025-11-05 | |
| 22 Oct 2025 | Capital | Allotment of shares (GBP 7,773.6046) on 2025-10-22 |
Change Person Secretary Company With Change Date
Appointment of Mr Malcolm Gates as director on 2026-03-05
Confirmation statement made on 2025-11-28 with updates
Allotment of shares (GBP 7,774.5756) on 2025-11-05
Allotment of shares (GBP 7,773.6046) on 2025-10-22
Recent Activity
Latest Activity
Change Person Secretary Company With Change Date
1 months ago on 10 Mar 2026
Appointment of Mr Malcolm Gates as director on 2026-03-05
1 months ago on 10 Mar 2026
Confirmation statement made on 2025-11-28 with updates
4 months ago on 12 Dec 2025
Allotment of shares (GBP 7,774.5756) on 2025-11-05
5 months ago on 20 Nov 2025
Allotment of shares (GBP 7,773.6046) on 2025-10-22
6 months ago on 22 Oct 2025